Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers

Sterile normal saline 0.9% administered IV as a placebo immediately before hyperbaric chamber exposure

Sterile normal saline 0.9% administered IV as a placebo immediately after hyperbaric chamber exposure

rhu-pGSN administered IV at a dose of 24 mg/kg immediately before hyperbaric chamber exposure

rhu-pGSN administered IV at a dose of 24 mg/kg immediately after hyperbaric chamber exposure

High-pressure profile equivalent 35 minutes at a depth of 30 meters of sea water